Bayer menopause drug reduces hot flashes in breast cancer group
Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...
Drug From Bowel Bacteria Helps Blood Cancer Patients Facing Deadly Complication
When Anne Maldzinski underwent a blood stem-cell transplant to cure her cancer, the procedure triggered a life-threatening ...
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo (Dec. 27)
By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an ...
Poynter2d
No, cancer isn’t a parasite, and ivermectin can’t cure it
Cancer grows from mutations in a person’s cells. Parasites are separate organisms that live on or in another host organism.
Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker
Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...
J&J's combo extends patients' lives in head-to-head study with AstraZeneca's drug
Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...
clinicaladvisor.com2d
Prostate Cancer Treatment Challenge: Which Drugs to Use First
A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...
Astra, Merck Drugs Set to Shake Up Liver Cancer Treatment
Doctors may change how they treat liver cancer after drugs from AstraZeneca Plc and Merck & Co. helped some patients, marking ...
Interesting Engineering on MSN8d
World’s first skin cancer treatment cream could replace surgery, radiotherapy
Researchers are developing the world’s first topical cream to prevent and treat skin cancer, especially for organ transplant ...
Targeted Oncology3d
Top 10 Lung Cancer Advances of 2024
Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...
Becker's Hospital Review23h
Drug extends survival in lung cancer patients: J&J
Johnson & Johnson released results from a phase 3 study, showing that the combination of Rybrevant and Lazcluze significantly improved overall survival in patients with advanced non-small cell lung ...